| Literature DB >> 36009729 |
Jolanta Karakulska1, Marta Woroszyło1, Małgorzata Szewczuk2, Karol Fijałkowski1.
Abstract
The study aimed to analyze staphylococcal microbiota of the nasal cavity of the primitive sheep breeds Polish Świniarka and Wrzosówka kept on the same ecological farm. The research included the identification of staphylococcal species, evaluation of the prevalence of genes encoding enterotoxins, staphylococcal enterotoxin-like proteins, exfoliative toxins, toxic shock syndrome toxin 1, and detection of antimicrobial resistance. From 61 swab samples gathered from Świniarka (33) and Wrzosówka (28) healthy sheep, 127 coagulase-negative staphylococci (CoNS) were isolated. Based on PCR-RFLP analysis of the gap gene using AluI and HpyCH4V enzymes, the isolates were identified as: Staphylococcus xylosus (33.9%), S. equorum (29.1%), S. arlettae (15%), S. warneri (9.4%), S. lentus (7.9%), S. succinus (3.9%) and S. sciuri (0.8%). Three of these species, S. lentus, S. succinus, and S. sciuri, were detected only from the Świniarka breed. It was found that 77.2% of isolates harbored from 1 to 7 out of 21 analyzed genes for superantigenic toxins. The greatest diversity of toxin genes was recorded for S. equorum (16 different genes). The most prevalent gene was ser (40.2%). The incidence and number of resistances to antimicrobials were found to be bacterial species but not sheep breed dependent. The highest percentage of resistance was found for S. sciuri. The most frequent resistance was observed to clindamycin (45.7%). The findings of this study prove that toxigenic and antimicrobial resistant CoNS can colonize the nasal cavity of healthy sheep.Entities:
Keywords: AluI enzyme; HpyCH4V enzyme; antimicrobial resistance; enterotoxin; exfoliative toxin; gap gene; primitive sheep breed; staphylococci; toxic shock syndrome toxin 1
Year: 2022 PMID: 36009729 PMCID: PMC9404845 DOI: 10.3390/ani12162139
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Figure 1Świniarka sheep.
Figure 2Wrzosówka sheep.
Identification of staphylococci isolated from Świniarka and Wrzosówka breed.
| PCR-RFLP Identification | Source of Isolation-Sheep Breed (No. of Isolates) | |||
|---|---|---|---|---|
| Świniarka (33) | Wrzosówka (28) | Świniarka + Wrzosówka (61) | ||
| No. of Isolates (%) | ||||
|
|
| 15 (34.9) | 28 (65.1) | 43 (33.9) |
|
|
| 23 (62.2) | 14 (37.8) | 37 (29.1) |
|
|
| 17 (89.5) | 2 (10.5) | 19 (15) |
|
|
| 2 (16.7) | 10 (83.3) | 12 (9.4) |
|
|
| 10 (100) | 0 (0) | 10 (7.9) |
|
|
| 5 (100) | 0 (0) | 5 (3.9) |
|
|
| 1 (100) | 0 (0) | 1 (0.8) |
|
|
|
| ||
Species diversity vs. a source of isolation of staphylococci.
| Sheep Breed | No. of Sheep (%) | No. of Isolates (%) | ||
|---|---|---|---|---|
|
| 33 (54.1) |
| 23 (31.5) | 73 (57.5) |
|
| 17 (23.3) | |||
|
| 15 (20.5) | |||
|
| 10 (13.7) | |||
|
| 5 (6.8) | |||
|
| 2 (2.7) | |||
|
| 1 (1.4) | |||
|
| 28 (45.9) |
| 28 (51.9) | 54 (42.5) |
|
| 14 (25.9) | |||
|
| 10 (18.5) | |||
|
| 2 (3.7) | |||
|
|
| |||
Distribution of superantigen (SAg) genes profile among Staphylococcus species.
| Species | No. of SAg Genes-Positive Isolates (%) | SAg Genes (No. of Isolates) | No. of SAg Genes |
|---|---|---|---|
|
| 34/43 (79.1) | ser (15), seg (14), selq (13), selm (9), selo (9), sed (7), tst-1 (7), sei (6), sec (4), sea (3), seh (2), seln (2), see (1), sell (1), etd (1) | 15 |
|
| 26/37 (70.3) | ser (12), seg (11), selm (11), selq (10), sei (7), selo (6), seln (4), sea (3), tst-1 (3), seb (1), sec (1), see (1), sell (1), selk (1), eta (1), etd (1) | 16 |
|
| 14/19 (73.7) | ser (9), selm (8), selq (5), sec (3), tst-1 (3), sea (2), seg (2), etd (2), sei (1), sed (1), sell (1), selo (1) | 12 |
|
| 9/12 (75) | ser (6), selq (4), seg (2), selm (2), selo (2), tst-1 (2), sei (1), sell (1) | 8 |
|
| 9/10 (90) | ser (7), selm (6), seg (5), selq (4), sei (3), sec (2), selo (2), tst-1 (2), sell (1), seln (1), selu (1), etd (1) | 12 |
|
| 5/5 (100) | seg (2), ser (2), selk (1), selm (1), selo (1), selq (1) | 6 |
|
| 1/1 (100) | selq (1) | 1 |
|
|
Relationship between source of isolation and prevalence of superantigen (SAg) genes among Staphylococcus species.
| Source of Isolation No. of Sheep (%) | Species (No. of Isolates) | No. of SAg Gene-Positive Isolates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 16 | 7 | 4 | 8 | 6 | 5 | 5 | 3 | 1 | 2 | 3 | 1 | 1 | ||||||||||
| 12 | 8 | 5 | 7 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||||||||||
| 11 | 7 | 4 | 1 | 4 | 2 | 3 | 2 | 2 | 1 | ||||||||||||||
| 9 | 7 | 4 | 6 | 5 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | |||||||||||
| 5 | 2 | 1 | 1 | 2 | 1 | 1 | |||||||||||||||||
| 1 | 1 | 1 | 1 | ||||||||||||||||||||
| 1 | 1 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
|
| 23 | 8 | 9 | 8 | 10 | 7 | 6 | 4 | 2 | 3 | 5 | 1 | 1 | 1 | 1 | 2 | |||||||
| 10 | 5 | 6 | 3 | 5 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||
| 8 | 5 | 3 | 2 | 1 | 2 | 1 | 2 | 1 | |||||||||||||||
| 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prevalence of superantigen (SAg) genes among Staphylococcus species.
| Species | SAg Genes | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| No. of SAg Gene-Positive Isolates | |||||||||||||||||||||
| 15 | 13 | 9 | 14 | 9 | 6 | 7 | 4 | 3 | 7 | 2 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12 | 10 | 11 | 11 | 6 | 7 | 3 | 1 | 3 | 0 | 4 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | |
| 9 | 5 | 8 | 2 | 1 | 1 | 3 | 3 | 2 | 1 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6 | 4 | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7 | 4 | 6 | 5 | 2 | 3 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| 2 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Relationship between a source of isolation and antimicrobial resistance of staphylococci.
| Source of Isolation (No. of Sheep) | Species (No. of Isolates) | No. of Resistant Isolates (%) | Antimicrobial | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of Resistant Isolates | |||||||||||||||
| FOX | E | DA | NOR | CIP | AK | CN | TGC | TE | LZD | SXT | RD | C | |||
|
| 4/23 (17.4) | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13/17 (76.5) | 0 | 5 | 10 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 2 | 0 | ||
| 11/15 (73.3) | 0 | 5 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | ||
| 9/10 (90) | 0 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | ||
| 2/5 (40) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | ||
| 2/2 (100) | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | ||
| 1/1 (100) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| 22/28 (78.6) | 0 | 12 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | |
| 4/14 (28.6) | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 8/10 (80) | 0 | 4 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | ||
| 1/2 (50) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
FOX—cefoxitin, E—erythromycin, DA—clindamycin, NOR—norfloxacin, CIP—ciprofloxacin, AK—amikacin, CN—gentamicin, TGC—tigecycline, TE—tetracycline, LZD—linezolid, SXT—trimetoprim/sulfamethoxazole, RD—rifampicin, C—chloramphenicol.
Antibiotic resistance of staphylococci.
| Species | No. of Isolates | Resistant Isolates (%) | Resistance Phenotypes (No. of Isolates) | Resistance Mechanisms (No. of Isolates) |
|---|---|---|---|---|
|
| 43 | 33/43 (76.7) | DA-RD (3), E (3), DA (11), E-DA (6), RD (2), E-DA-RD (8) | cMLSB (14), iMLSB (3), MSB (1), L phenotype (14) |
|
| 37 | 8/37 (21.6) | E (8) | MSB (8) |
|
| 19 | 14/19 (73.7) | CN-DA (1), E (2), TE (1), E-DA (1), DA (7), E-DA-RD (2) | cMLSB (3), iMLSB (2), L phenotype (8) |
|
| 12 | 10/12 (83.3) | E-DA-RD (6), DA-RD (2), DA (2) | cMLSB (6), L phenotype (4) |
|
| 10 | 9/10 (90) | DA (6), DA-LZD (2), E (1) | iMLSB (1), L phenotype (8) |
|
| 5 | 2/5 (40) | RD (2) | - |
|
| 1 | 1/1 (100) | DA (1) | L phenotype (1) |
|
|
|
|
CN—gentamicin, DA—clindamycin, E—erythromycin, LZD—linezolid, RD—rifampicin, TE—tetracycline.